Syndax Pharmaceuticals Inc (SNDX)
19.27
-0.02
(-0.10%)
USD |
NASDAQ |
May 31, 16:00
19.25
-0.02
(-0.10%)
After-Hours: 20:00
Syndax Pharmaceuticals Accounts Payable (Quarterly): 16.36M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 16.36M |
December 31, 2023 | 17.19M |
September 30, 2023 | 6.049M |
June 30, 2023 | 10.98M |
March 31, 2023 | 8.057M |
December 31, 2022 | 4.35M |
September 30, 2022 | 7.115M |
June 30, 2022 | 6.438M |
March 31, 2022 | 8.231M |
December 31, 2021 | 5.669M |
September 30, 2021 | 5.122M |
June 30, 2021 | 3.624M |
March 31, 2021 | 6.529M |
December 31, 2020 | 3.508M |
September 30, 2020 | 3.836M |
June 30, 2020 | 1.832M |
March 31, 2020 | 8.998M |
December 31, 2019 | 6.178M |
September 30, 2019 | 6.757M |
June 30, 2019 | 2.276M |
Date | Value |
---|---|
March 31, 2019 | 4.35M |
December 31, 2018 | 1.439M |
September 30, 2018 | 3.18M |
June 30, 2018 | 5.297M |
March 31, 2018 | 2.59M |
December 31, 2017 | 2.232M |
September 30, 2017 | 2.246M |
June 30, 2017 | 3.362M |
March 31, 2017 | 2.741M |
December 31, 2016 | 2.375M |
September 30, 2016 | 2.01M |
June 30, 2016 | 1.588M |
March 31, 2016 | 2.225M |
December 31, 2015 | 1.452M |
September 30, 2015 | 1.24M |
December 31, 2014 | 0.354M |
September 30, 2014 | 0.397M |
June 30, 2014 | 0.928M |
March 31, 2014 | 0.805M |
December 31, 2013 | 1.077M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.832M
Minimum
Jun 2020
17.19M
Maximum
Dec 2023
6.955M
Average
6.308M
Median
Accounts Payable (Quarterly) Benchmarks
Geron Corp | 9.992M |
Verastem Inc | 7.449M |
Karyopharm Therapeutics Inc | 5.028M |
Crinetics Pharmaceuticals Inc | 10.76M |
Arvinas Inc | 17.80M |